SEC Form 4 · accession 0001179110-16-026913
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas P Koestler
Director
Period of report
Jun 23, 2016
Accepted (ET)
Jun 27, 2016 · 2:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 23, 2016 | A | 5,500 | $0.00 | A | 5,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $10.97 | Jun 23, 2016 | A | 11,000 | A | Jun 23, 2017 | Jun 23, 2026 | Common Stock | 11,000 | 11,000 | D |
Explanation of responses
- F1Represents 5,500 shares of restricted common stock, $0.0001 par value per share, awarded pursuant to the Company's 2013 Stock Incentive Plan, 100% of the shares of restricted common stock shall vest on the first anniversary of the grant date, subject to Dr. Koestler's continued service to the Company.
- F2Represents an option granted by the Company pursuant to the Company's 2013 Stock Incentive Plan. The stock option will vest and become exercisable on the first anniversary of the grant date, subject to Dr. Koestler's continued service to the Company.